The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
Abstract
BACKGROUND Whole breast irradiation delivered once per day over 3-5 weeks after breast conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial breast irradiation (APBI) delivered over 1 week to the tumour bed was developed to provide a more convenient treatment. In this trial, we investigated if external beam APBI was non-inferior to whole breast irradiation. METHODS We did this multicentre, randomised, non-inferiority trial in 33 cancer centres in Canada, Australia and New Zealand. Women aged 40 years or older with ductal carcinoma in situ or node-negative breast cancer treated by breast conserving surgery were randomly assigned (1:1) to receive either external beam APBI (38·5 Gy in ten fractions delivered twice per day over 5-8 days) or whole breast irradiation (42·5 Gy in 16 fractions once per day over 21 days, or 50 Gy in 25 fractions once per day over 35 days). Patients and clinicans were not masked to treatment assignment. The primary outcome was ipsilateral breast tumour recurrence (IBTR), analysed by intention to treat. The trial was designed on the basis of an expected 5 year IBTR rate of 1·5% in the whole breast irradiation group with 85% power to exclude a 1·5% increase in the APBI group; non-inferiority was shown if the upper limit of the two-sided 90% CI for the IBTR hazard ratio (HR) was less than 2·02. This trial is registered with ClinicalTrials.gov, NCT00282035. FINDINGS Between Feb 7, 2006, and July 15, 2011, we enrolled 2135 women. 1070 were randomly assigned to receive APBI and 1065 were assigned to receive whole breast irradiation. Six patients in the APBI group withdrew before treatment, four more did not receive radiotherapy, and 16 patients received whole breast irradiation. In the whole breast irradiation group, 16 patients withdrew, and two more did not receive radiotherapy. In the APBI group, a further 14 patients were lost to follow-up and nine patients withdrew during the follow-up period. In the whole breast irradiation group, 20 patients were lost to follow-up and 35 withdrew during follow-up. Median follow-up was 8·6 years (IQR 7·3-9·9). The 8-year cumulative rates of IBTR were 3·0% (95% CI 1·9-4·0) in the APBI group and 2·8% (1·8-3·9) in the whole breast irradiation group. The HR for APBI versus whole breast radiation was 1·27 (90% CI 0·84-1·91). Acute radiation toxicity (grade ≥2, within 3 months of radiotherapy start) occurred less frequently in patients treated with APBI (300 [28%] of 1070 patients) than whole breast irradiation (484 [45%] of 1065 patients, p<0·0001). Late radiation toxicity (grade ≥2, later than 3 months) was more common in patients treated with APBI (346 [32%] of 1070 patients) than whole breast irradiation (142 [13%] of 1065 patients; p<0·0001). Adverse cosmesis (defined as fair or poor) was more common in patients treated with APBI than in those treated by whole breast irradiation at 3 years (absolute difference, 11·3%, 95% CI 7·5-15·0), 5 years (16·5%, 12·5-20·4), and 7 years (17·7%, 12·9-22·3). INTERPRETATION External beam APBI was non-inferior to whole breast irradiation in preventing IBTR. Although less acute toxicity was observed, the regimen used was associated with an increase in moderate late toxicity and adverse cosmesis, which might be related to the twice per day treatment. Other approaches, such as treatment once per day, might not adversely affect cosmesis and should be studied. FUNDING Canadian Institutes for Health Research and Canadian Breast Cancer Research Alliance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
The linear-quadratic formula and progress in fractionated radiotherapy
Fowler, J. F. (1989) · The British Journal of Radiology · doi:10.1259/0007-1285-62-740-679 · Cited by 2,252
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Self-citationSmith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.031 · Cited by 872
Self-citationVaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D. J., Keshtgar, M., Flyger, H. L., Massarut, S., Alvarado, M., Saunders, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61950-9 · Cited by 831
Veronesi, U., Orecchia, R., Maisonneuve, P., Viale, G., Rotmensz, N., Sangalli, C., Luini, A., Veronesi, P., Galimberti, V., Zurrida, S., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70497-2 · Cited by 767
Radiotherapy after Breast-Preserving Surgery in Women with Localized Cancer of the Breast
Veronesi, U., Luini, A., Del Vecchio, M., Greco, M., Galimberti, V., Merson, M., Rilke, F., Sacchini, V., Saccozzi, R., Savio, T., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306033282202 · Cited by 751
Veronesi, U., Marubini, E., Mariani, L., Galimberti, V., Luini, A., Veronesi, P., Salvadori, B., & Zucali, R. (2001) · Annals of Oncology · doi:10.1023/a:1011136326943 · Cited by 747
Strnad, V., Ott, O. J., Hildebrandt, G., Kauer-Dorner, D., Knauerhase, H., Major, T., Lyczek, J., Guinot, J. L., Dunst, J., Miguelez, C. G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00471-7 · Cited by 659
Cited by
Murray Brunt, A., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Alhasso, A., Bloomfield, D. J., Chan, C., Churn, M., Cleator, S., Coles, C. E., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30932-6 · Cited by 1,084
Self-citationBreast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 951
Burstein, H. J., Curigliano, G., Thürlimann, B., Weber, W. P., Poortmans, P., Regan, M. M., Senn, H. J., Winer, E. P., Gnant, M., Aebi, S., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.06.023 · Cited by 821
Self-citationMeattini, I., Marrazzo, L., Saieva, C., Desideri, I., Scotti, V., Simontacchi, G., Bonomo, P., Greto, D., Mangoni, M., Scoccianti, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00650 · Cited by 443
Vaidya, J. S., Bulsara, M., Baum, M., Wenz, F., Massarut, S., Pigorsch, S., Alvarado, M., Douek, M., Saunders, C., Flyger, H. L., et al. (2020) · BMJ · doi:10.1136/bmj.m2836 · Cited by 293
Metadata
- Authors
- Whelan, T. J., Julian, J. A., Berrang, T. S., Kim, D.-H., Germain, I., Nichol, A. M., Akra, M., Lavertu, S., Germain, F., Fyles, A., Trotter, T., Perera, F. E., Balkwill, S., Chafe, S., McGowan, T., Muanza, T., Beckham, W. A., Chua, B. H., Gu, C. S., Levine, M. N., Olivotto, I. A., Leong, C., Lester, B. H., Kwan, W. B., Abd-El-Malek, M. Z., Cheung, A., Almahmudi, M., Broomfield, J., Sia, M., Reed, M. J., Wilson, J., Mohamed, I. G., Holloway, C., Mills, K., Petrik, D. W., Crook, J. M., Wong, F. L.-W., Mills Carolan, H., Voduc, D., Ingledew, P.-A., Nguyen, S., Keyes, M., Weir, L. M., Tyldesley, S., Lim, P., Aquino Parsons, C., Olson, R., Blood, P., Wai, E. S.-S., Truong, P., Kader, H. (., Alexander, A., Mohd Mydin, A. R., Smith, S., Vlachaki, M., Panet-Raymond, V., Lupe, K., Goulart, J., Nguyen, D., Chu, K., Canavan, J., Caon, J., Tyler, S., Shahid, N., Lam, J., Amanie, J., Severin, D. M., Abdul Karim, B., Tankel, K., Pervez, N., Joseph, K., Gabos, Z., Krause, B., Huang, F., Phan, T., Craighead, P., Yan, E., MacKinnon, J. A. (., Nordal, R., Husain, S., Voroney, J.-P., Sinha, R., Pinilla, J., Cooke, A., Vijayraghavan, K., Latosinsky, S., Saettler, E., Lau, Y.-K. (., Krahn, M., MacIntosh, E., Nashed, M., Bashir, B., Torri, V., Goldenberg, B., Kim, C., Basrur, V., Rachakonda, R., Gopaul, D., Shahi, S., Kobeleva, S., Dayes, I., Hodson, D., Strang, B., Voruganti, S., McMillan, W., Reiter, H., Wright, J., Sussman, J., Mukherjee, S., Gudelis, S., D'Souza, D., Lock, M., Read, N., Vujovic, O., Yaremko, B., Yu, E., Vandenberg, T., Younus, J., Potvin, K., Sexton, T., Dingle, B., Findlay, B., Giesbrecht, J., Hughes, P., Samosh, M., Levesque, M., Yelamanchili, R., Lee, L., VanderMeer, R., Wasserman, D., Bowen, J., Want, D., Bissett, R., Andronowski, A., Shehata, S., Prichard, H. L., Koll, W., Chan, P. C., Mui, J., Youssef, Y. M., Campbell, H., El-Mallah, M., Iqbal, F., Banihashemi, B. (., Dixon, P., Grimard, L., Lochrin, C., Meng, J., Cross, P., El-Sayed, S., Esche, B., Genest, P., Caudrelier, J.-M., Morgan, S., Bourque, J.-M., Nair, V., Senthelal, S., Jones, G., Tsao, J., Radwan, J., Hayter, C., Finlay, M., Lian, J. (., Wang, Y., Yuen, J., Khan, L., Cho, B. C. J., Koch, C. A., Liu, F.-F., Manchul, L. A., McLean, M., Catton, P., Dinniwell, R. E., Wells, W. A., Levin, W., Walsh, L., Chung, C., Han, K., Conrad, T., Helou, J., Barry, A., Schneider, K., Hirmiz, K., Abu-Zahra, H. T., Roy, I., Ayllon, J., Del Vecchio, P., Fortin, M.-A., Guay, J.-P., Methot, F., Rousseau, P., Jolicoeur, M., Vu, T., Igidbashian, L., Dagnault, A., Diaz de Bedoya, L.-V., Wang, C. S., Fortin, A., Vigneault, E., Vallieres, I., Raymond, P.-E., Martin, A.-G., Blondeau, L., Larochelle, M., Lessard, N., Gaudreault, M., Théberge, V., Nabid, A., Ballivy, O., Bujold, R., Ebacher, A., Provencher, S., Chabot, P., Lemaire, C., Vavassis, P., Menkarios, C., Yassa, M., Sultanem, K., Panasci, L., Melnychuk, D., Patenaude, F., Miller, W., Mihalioiu, C., Ahlgren, P., Dalfen, R., Langleben, A., Stern, D., Wan, J., Lambert, C., David, M., Kopek, N., Carbonneau, A., Hijal, T., Grant, N., Naz, F., Mohiuddin, M. D., Kumar, S. E., Rutledge, R., Rheaume, D. E., Nolan, M. C., Cwajna, W., Gill, S., Gleisner, T., Grenfell, S., Bishop, M., Thiruthaneeswaran, N., Liu, C., Philips, C., Drummond, R., King, B., David, S. P., Dwyer, M. K., Campbell, G., Brooks, S., Arunachalam, R., Sasso, G., Benjamin, C., Jose, C., Elder, C., Krawitz, H., Lee, D., Huang, R., Purchuri, S., Pearse, M., Hemanth, T., Angell, R., Patel, V., Round, G., Chaudhuri, A., & Ford, C.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 394
- Issue
- 10215
- Pages
- 2165-2172
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2992619229
- Cited by
- 427
- References
- 23
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(19)32515-2
- The paper
- Whelan, T. J., Julian, J. A., Berrang, T. S., Kim, D.-H., Germain, I., Nichol, A. M., Akra, M., Lavertu, S., Germain, F., Fyles, A., Trotter, T., Perera, F. E., Balkwill, S., Chafe, S., McGowan, T., Muanza, T., Beckham, W. A., Chua, B. H., Gu, C. S., . . . Ford, C. (2019). External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(19)32515-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.